Key Stats for MU Stock 30-Day Performance: 54% 54% 52-Week Range: $92 to $819 $92 to $819 Valuation Model Target Price: Around $1,030 Around $1,030 Implied Upside: 37% Analyze your favorite stocks like Micron Technology with TIKR (It’s free) >>> What Happened? Micron Technology, Inc. stock rose about 54% over the last 30 days, finishing near $751 per share as investors repriced the company around ...
Key Stats for MU Stock 30-Day Performance: 54% 54% 52-Week Range: $92 to $819 $92 to $819 Valuation Model Target Price: Around $1,030 Around $1,030 Implied Upside: 37% Analyze your favorite stocks like Micron Technology with TIKR (It’s free) >>> What Happened? Micron Technology, Inc. stock rose about 54% over the last 30 days, finishing near $751 per share as investors repriced the company around one of the market’s strongest AI infrastructure stories: tight memory supply, rising AI server demand, and improving prices for DRAM, NAND, and high-bandwidth memory. Micron makes memory and storage chips, and the key debate is whether AI data centers can keep driving demand for HBM, the high-bandwidth memory used with advanced AI accelerators from companies like Nvidia. The rally also reflects stronger sentiment across memory peers such as SK Hynix and Samsung Electronics, Micron’s closest DRAM and HBM competitors, while Western Digital, Kioxia, and Seagate remain relevant as NAND and enterprise SSD demand improves. The stock moved higher because analyst target increases, stronger DRAM and NAND pricing, and tight HBM supply gave investors more confidence that Micron’s pricing power could last into 2026 and 2027. Mizuho raised its Micron price target to $800 from $740 and kept an Outperform rating, citing stronger NAND and DRAM pricing into the second half of 2026 and 2027, while Citi raised its target to $840 from $425 and kept a Buy rating as it pointed to stronger DRAM pricing and more upside from HBM. That matters because Micron’s profit story is increasingly tied to selling scarce AI memory at better prices, not just shipping more chips. This week’s J.P. Morgan conference update added more support to the bullish story. EVP of Global Operations Manish Bhatia said Micron’s financial outlook has strengthened since its last earnings call and that the company is on track for “another substantial record free cash flow” in fiscal Q3. He also said demand continues to outpace i...
Island of Ireland sees another temperature record for May Temperatures in Northern Ireland are not likely to be as high as those in the Republic of Ireland.
Island of Ireland sees another temperature record for May Temperatures in Northern Ireland are not likely to be as high as those in the Republic of Ireland.
PM Images/DigitalVision via Getty Images The last time I wrote about Biogen Inc. ( BIIB ) was at the end of 2025, in the article . In it, I mainly discussed Biogen's Q4 earnings and Vumerity, the so-called successor to Tecfidera, which was once viewed as the "gold standard" in the treatment of relapsing forms of MS . Table was made by Author I also pointed out Leqembi's key competitive advantages ...
PM Images/DigitalVision via Getty Images The last time I wrote about Biogen Inc. ( BIIB ) was at the end of 2025, in the article . In it, I mainly discussed Biogen's Q4 earnings and Vumerity, the so-called successor to Tecfidera, which was once viewed as the "gold standard" in the treatment of relapsing forms of MS . Table was made by Author I also pointed out Leqembi's key competitive advantages over Eli Lilly's Kisunla ( LLY ), which will help it continue to gain share in the Alzheimer's therapeutics market. So, what interesting things happened in the past 5 months? And do I still think BIIB's risk/reward ratio is attractive? First of all, promising biomarker results from its Alzheimer's Disease ("AD") Phase 2 CELIA trial [ NCT05399888 ] of diranersen were overshadowed 7 days later by the failure of BIIB122 in the Phase 2b LUMA study [ NCT05348785 ]. In it, BIIB122, or Biogen/Denali's LRRK2 inhibitor ( DNLI ), failed to slow the progression of Parkinson's disease compared to placebo, as measured by the MDS-UPDRS score. And what's more critical, in my opinion, is that Biogen has no product candidates targeting this movement disorder of the nervous system. Graph was made by Author based on Biogen On the other hand, I believe this setback was offset by its strong first-quarter report. So, Biogen's revenue rose 8.8% QoQ to $2.48 billion , once again beating Wall Street analysts' expectations by $231.7 million. Meanwhile, its non-GAAP EPS of $3.57 also came in well above the consensus estimate, as in the last 9 quarters, but this time by 68 cents . Graph was made by Author based on Seeking Alpha Apellis Pharmaceuticals' Empaveli/Syfovre strengthens Biogen's position in the rare disease and geographic atrophy markets As a reminder, on May 14, Biogen announced the completion of its $5.6 billion buyout of Apellis . Furthermore, Apellis shareholders are eligible to receive two payments of $2 per share each if certain sale thresholds are reached for its Syfovre [ pegcetacop...
Terra Quantum AG and Axiom Intelligence Acquisition ( AXINU ) will merge under a SPAC deal that will result in the former becoming a publicly listed company, the company said on Tuesday. The transaction values Terra Quantum at an equity value of ~$3.5 billion. Upon closing, existing Terra Quantum shareholders are expected to own ~92% of the combined company, and Axiom's public stockholders and spo...
Terra Quantum AG and Axiom Intelligence Acquisition ( AXINU ) will merge under a SPAC deal that will result in the former becoming a publicly listed company, the company said on Tuesday. The transaction values Terra Quantum at an equity value of ~$3.5 billion. Upon closing, existing Terra Quantum shareholders are expected to own ~92% of the combined company, and Axiom's public stockholders and sponsor are expected to own ~8%. Following the transaction, the combined company will operate under the Terra Quantum name and is expected to trade on the Nasdaq Stock Market under the ticker symbol "TQ." Based on the funds in the trust account at the time of the IPO, the transaction is expected to deliver up to ~$190M of gross proceeds to the combined company. The transaction is targeted to close in the second half of 2026. Source: Press Release More on Axiom Intelligence Acquisition Corp 1 Financial information for Axiom Intelligence Acquisition Corp 1
This breakneck tech rally still has legs—and it’s driving the stock market higher. The tech rally was being driven by chip stocks again, as Intel climbed 2.8%, Micron Technology jumped 6%, and Sandisk added 3.3% ahead of the opening bell. The on-again, off-again talks between the U.S. and Iran have led to oil prices sliding—and oil stocks were weighing on the S&P 500 and the Dow.
This breakneck tech rally still has legs—and it’s driving the stock market higher. The tech rally was being driven by chip stocks again, as Intel climbed 2.8%, Micron Technology jumped 6%, and Sandisk added 3.3% ahead of the opening bell. The on-again, off-again talks between the U.S. and Iran have led to oil prices sliding—and oil stocks were weighing on the S&P 500 and the Dow.
AlexSecret/iStock via Getty Images The S&P 500 ( SPX ) rose 0.8% above its previous week's close to end the trading week at 7,473.45 on Friday, 22 May 2026, as investors went into the Memorial Day holiday weekend. In doing so, the index confirmed that stock prices have fully recovered from the Iran war impact. We find the trajectory of the S&P 500 falls very close to the central trend line of the ...
AlexSecret/iStock via Getty Images The S&P 500 ( SPX ) rose 0.8% above its previous week's close to end the trading week at 7,473.45 on Friday, 22 May 2026, as investors went into the Memorial Day holiday weekend. In doing so, the index confirmed that stock prices have fully recovered from the Iran war impact. We find the trajectory of the S&P 500 falls very close to the central trend line of the redzone forecast range we added to the alternative futures chart back on 23 February 2026 , several days ahead of when the geopolitical event began. For us, that timing has been fortunate because the redzone forecast range has been able to function as a counterfactual projection of how the S&P 500 would have changed if the Iran war geopolitical event had never happened. So for the trajectory of stock prices to fall so neatly near the middle of that forecast range now that we're coming to its end is a strong confirmation the negative shock of the geopolitical event upon them has fully waned. Here is the latest update of the alternative futures chart that shows that outcome: The redzone forecast range is based on the assumption investors would primarily focus on 2026-Q2 in making the decisions that set the trajectory of stock prices throughout its run. The Iran War geopolitical event didn't alter that focus throughout this period but rather added noise on top of the signal provided by the dividend futures-based model we use to forecast the S&P 500's future. There are other factors that affect both the signal and noise investors consider in their decision making, which is provided from the random onset of new information. Here are the past week's market-moving headlines. Monday, 18 May 2026 Signs and portents for the U.S. economy: China to buy at least $17 billion in US agricultural products annually, White House says Explainer: What do China's new US farm purchases mean for global trade? White House gets small rare earth win, but China's export regime is here to stay Trump re...
shih-wei/E+ via Getty Images Market Overview Q1 2026 featured recurring shifts between risk-on and risk-off as investors weighed evolving geopolitical risks, trade-policy uncertainty, and mixed monetary policy signals, with late-quarter attention increasingly dominated by the Iran conflict and its implications for energy supply and shipping routes, which heightened inflation sensitivity and contri...
shih-wei/E+ via Getty Images Market Overview Q1 2026 featured recurring shifts between risk-on and risk-off as investors weighed evolving geopolitical risks, trade-policy uncertainty, and mixed monetary policy signals, with late-quarter attention increasingly dominated by the Iran conflict and its implications for energy supply and shipping routes, which heightened inflation sensitivity and contributed to bouts of equity and rate volatility into quarter end. Trade-policy developments added another layer of uncertainty as key tariffs were challenged in court and the administration explored alternative paths, keeping the end-of-quarter outlook for global trade conditions unsettled. Against that backdrop, inflation data and Federal Reserve (Fed) communications supported a cautious policy stance, with markets balancing evidence of cooling underlying inflation in some releases against the risk that higher energy costs could reintroduce price pressures. Emerging markets held up best, developed markets were next, and US equities lagged as leadership broadened beyond growth, leaving value ahead of growth. In fixed income, core bonds were steadier than plus sectors as rate moves and weaker risk sentiment pressured spread 1 -sensitive credit, while the yield curve reflected ongoing inflation and policy uncertainty. Performance Summary The Hartford Checks and Balances Fund (I Share) underperformed its blended benchmark. Performance of the underlying funds was mixed: the Hartford Dividend and Growth Fund outperformed its benchmark, the S&P 500 Index, by 1.46%. The Hartford Capital Appreciation Fund underperformed its benchmark, the Russell 3000 Index, by -1.72%, and the Hartford Total Return Bond ETF underperformed its benchmark, the Bloomberg US Aggregate Bond Index, by -0.14% in the quarter. Positioning & Outlook We remain constructive on equities despite elevated volatility. While geopolitical risks have increased near-term uncertainty, we believe the medium-term backdrop fo...
The second quarter of the year has been a rocky one for aerospace and telecommunication services newcomer AST SpaceMobile NASDAQ: ASTS. Between a failed BlueBird satellite deployment in April and a monumental Q1 FY2026 earnings miss in May, headline risk has put considerable pressure on ASTS. Get AST SpaceMobile alerts: Sign Up But the stock’s dramatic price swings are nothing new to shareholders....
The second quarter of the year has been a rocky one for aerospace and telecommunication services newcomer AST SpaceMobile NASDAQ: ASTS. Between a failed BlueBird satellite deployment in April and a monumental Q1 FY2026 earnings miss in May, headline risk has put considerable pressure on ASTS. Get AST SpaceMobile alerts: Sign Up But the stock’s dramatic price swings are nothing new to shareholders. The volatile yet popular SpaceX competitor hasn’t just proven resilient; it has proven time and time again that it is capable of defying analyst ratings. Over the past month, the stock has gained more than 37%, and since its year-to-date low on May 5, ASTS has surged nearly 66%. AST SpaceMobile, Inc. (ASTS) Price Chart for Tuesday, May, 26, 2026 Now, on the back of a proposed joint venture announcement from strategic partners AT&T NYSE: T, T-Mobile NASDAQ: TMUS, and Verizon NYSE: V, the space-based cellular company is eyeing mid-June for the deployment of the next three satellites in its direct-to-device (D2D) constellation. AST SpaceMobile’s June Launch Becomes a Key Test After BlueBird 7 AST SpaceMobile Today ASTS AST SpaceMobile $125.88 +20.02 (+18.91%) 52-Week Range $22.47 ▼ $129.89 Price Target $79.45 Add to Watchlist Currently, AST SpaceMobile has six BlueBird satellites—the largest commercial arrays currently in low Earth orbit (LEO)—deployed. That figure should be seven, but on April 19, Blue Origin’s New Glenn rocket deposited BlueBird 7 into an altitude too low for it to sustain operations. BlueBird 7 has since been deorbited with the cost absorbed by AST SpaceMobile’s insurers, leaving the company’s total satellites in orbit at six and sparking speculation that the Midland, Texas-based company will not be able to meet its 2026 launch target. That goal remains lofty, with the company aiming for 45 to 60 BlueBirds in LEO by year’s end. But BlueBird 8, 9, and 10 are tentatively scheduled for June launches, which would go a long way in keeping AST SpaceMobile on tra...
Key Points Multiple giant defense stocks have seen big swings in their share prices during 2026. Amid volatility, dividend increases are not something investors need to wonder about for these three stocks. This includes two of the world's largest defense contractors with yields solidly above 1.5%. Top stocks in the aerospace and defense industry have experienced a lot of volatility in 2026. Multip...
Key Points Multiple giant defense stocks have seen big swings in their share prices during 2026. Amid volatility, dividend increases are not something investors need to wonder about for these three stocks. This includes two of the world's largest defense contractors with yields solidly above 1.5%. Top stocks in the aerospace and defense industry have experienced a lot of volatility in 2026. Multiple names are way down from their recent highs, with upward price action largely mirroring the initial ratcheting up of tensions in Iran. Now, as the conflict has shown signs of de-escalation, share prices have come down. Despite this, companies are holding one thing steady—their commitment to provide more dividend income to shareholders, with key stocks boosting their dividends. Northrup Goes on a Rollercoaster Ride in 2026, Dividend Pushes Higher First up is Northrup Grumman (NYSE: NOC), known by many for building highly advanced stealth aircraft for the U.S. government, such as the B-2 Spirit. Notably, the stock peaked at a 37% year-to-date return in 2026 in early March, just days after the conflict in Iran began. However, shares have fallen massively since that point, now down slightly on the year. The stock saw a huge 10.3% plunge after its Q1 2026 earnings release. This came as Northrup beat estimates on sales and adjusted earnings per share (EPS) during the quarter, but did not raise its full-year guidance. Due to this, the company’s guidance came in below expectations. However, in another positive, Northrup announced an acceleration of the timeline for its Air Force Sentinel missile program, with first flight expected in 2027. Despite the stock’s huge rise and fall, Northrup showed confidence in its outlook by announcing a significant 7% dividend increase. The company’s quarterly dividend will move up to $2.47 per share. The firm plans to make its next payment on June 17 to shareholders of record as of the June 1 close. Overall, Northrup holds a solid indicated divid...
Jonathan Andic, son of Mango founder Isak Andic, said on Tuesday he was stepping down temporarily as the fashion group’s vice chair after being named a suspect in an investigation into his father’s death, while strongly asserting his innocence. “The attention and focus that my defence in the judicial process currently requires do not allow me to maintain the high level of commitment demanded by my...
Jonathan Andic, son of Mango founder Isak Andic, said on Tuesday he was stepping down temporarily as the fashion group’s vice chair after being named a suspect in an investigation into his father’s death, while strongly asserting his innocence. “The attention and focus that my defence in the judicial process currently requires do not allow me to maintain the high level of commitment demanded by my role at the company,” Andic said in an open letter to staff. “A public narrative has been constructed that is one-sided, taken out of context and distorted, and which has created a perception of guilt that bears no relation to reality. I know that dismantling it will require time, effort and intense dedication.” Advertisement Spanish court last week named Andic as a suspect in the death of his father, who died in December 2024 after falling more than 100 metres (330 feet) from a cliff while the two were hiking together in the mountains outside Barcelona. Pedestrians walk by the entrance of a Mango shop on Passeig de Gracia street in Barcelona. Photo: AFP In the letter, Andic described his father’s death as a devastating personal loss and said he had since been forced to live under what he called an unfounded and deeply unjust accusation.